Around 13.4% of the world’s population suffers from chronic kidney disease1 and acute kidney injuries occur in 23% of hospitalized patients2… and yet renal dosing continues to be a challenge worldwide because there has not been a gold standard for those recommendations. Until now.
At Lexicomp, we make it our business to tackle the most critical and challenging areas of drug decision support, and this is just one example. We gathered world-renowned experts in nephrology and pharmacology to expand and advance renal dosing content and provide clinical context for those recommendations. Where other drug information may provide the basics, we have an unparalleled commitment to supporting clinicians as they make decisions not only in the straightforward cases, but in the most complex. We achieve this through our unmatched multidisciplinary editorial team that anticipates clinicians’ needs when treating patients with varied medical conditions, and through our formulary and advanced machine learning technology, delivering that relevant information quickly and across solutions.
Expert editorial team, providing breadth and depth of content
We never stop advancing our content. As new evidence emerges, our expert editorial team incorporates it into the drug information you need to make decisions. And, because our 7,400-person team includes so many pharmacists and clinicians, they understand and seek to address the most challenging areas of dosing, ordering, and administering medications in hospital and retail settings. This allows them to deliver the breadth and depth of content that is critical to providing clinicians with information they need to make patient care decisions based on the latest evidence.
Recent content expansions include the following, inspired by their experience in the field and feedback from customers like you.